Azzad Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$630K Buy
2,790
+6
+0.2% +$1.27K 0.06% 287
2026
Q2
$601K Buy
+2,784
New +$533K 0.05% 289
2022
Q4
– Sell
-5,438
Closed -$1.45M – 320
2022
Q3
$1.45M Sell
5,438
-9
-0.2% -$1.91K 0.15% 207
2022
Q2
$1.44M Buy
+5,447
New +$1.11M 0.14% 213
2021
Q2
– Sell
-6,411
Closed -$1.79M – 325
2021
Q1
$1.79M Buy
6,411
+216
+3% +$58.3K 0.3% 141
2020
Q4
$1.52M Sell
6,195
-40
-0.6% -$10.3K 0.28% 146
2020
Q3
$1.77M Buy
6,235
+997
+19% +$278K 0.37% 103
2020
Q2
$1.4M Buy
5,238
+2,402
+85% +$722K 0.33% 113
2020
Q1
$897K Sell
2,836
-5,179
-65% -$1.57M 0.26% 142
2019
Q4
$2.23M Buy
8,015
+42
+0.5% +$11.7K 0.26% 138
2019
Q3
$2.04M Buy
7,973
+5,258
+194% +$1.22M 0.25% 144
2019
Q2
$635K Buy
2,715
+1,117
+70% +$258K 0.17% 203
2019
Q1
$378K Sell
1,598
-22
-1% -$6.93K 0.11% 247
2018
Q4
$488K Sell
1,620
-118
-7% -$37.7K 0.16% 214
2018
Q3
$614K Sell
1,738
-17
-1% -$5.85K 0.16% 212
2018
Q2
$509K Buy
1,755
+35
+2% +$9.8K 0.15% 231
2018
Q1
$471K Buy
1,720
+47
+3% +$14.6K 0.14% 231
2017
Q4
$533K Buy
1,673
+79
+5% +$25.3K 0.17% 191
2017
Q3
$499K Buy
1,594
+94
+6% +$27.8K 0.17% 200
2017
Q2
$407K Buy
1,500
+132
+10% +$34.9K 0.15% 221
2017
Q1
$374K Buy
1,368
+127
+10% +$35.9K 0.14% 217
2016
Q4
$352K Buy
1,241
+44
+4% +$13K 0.15% 209
2016
Q3
$375K Sell
1,197
-19
-2% -$5.63K 0.15% 207
2016
Q2
$294K Buy
1,216
+420
+53% +$111K 0.13% 222
2016
Q1
$207K Buy
796
+116
+17% +$30.6K 0.09% 230
2015
Q4
$208K Buy
+680
New +$195K 0.1% 229

Other funds holding BIIB

Azzad Asset Management's BIIB Position: Q3 2026 in Review

Azzad Asset Management increased its Biogen (BIIB) stake by 0.22% in Q3 2026, buying an estimated $1.27K and bringing the position to 2,790 shares worth $630K. The position accounts for 0.06% of the portfolio, ranked #287.

Azzad Asset Management first reported a position in BIIB in Q4 2015 and has held it in 26 quarters since. The position peaked at $2.23M in Q4 2019. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Azzad Asset Management held 2,790 shares of Biogen worth $630K as of Q3 2026.
  • Azzad Asset Management bought 6 Biogen shares in Q3 2026, an estimated $1.27K.
  • Biogen made up 0.06% of Azzad Asset Management's portfolio in Q3 2026, its #287 holding.
  • Azzad Asset Management first reported a position in Biogen in Q4 2015 and has held it in 26 quarters since.
  • Azzad Asset Management's Biogen position peaked at $2.23M in Q4 2019.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Azzad Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.